RecruitingNCT05326620
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
PROspective Renal Cancer Cohort (PRO-RCC)
Sponsor
PROspective Renal Cancer Cohort Foundation
Enrollment
2,000 participants
Start Date
Jan 19, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an infrastructure for observational research and (randomized) interventional studies with the TwiCs (Trial within cohorts) design.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- newly diagnosed patients with RCC or synchronous metastatic RCC
- metachronous metastasized RCC
- age \>18 years
- capable of understanding Dutch language
Exclusion Criteria1
- n/a
Locations(27)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05326620
Related Trials
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT0498150913 locations
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT0711504311 locations
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
NCT057386948 locations
64Cu-GRIP B in Patients With Advanced Malignancies
NCT058885321 location